SOAT1 and neoplasm: Based on this context, it is required to develop more promising pharmacological inhibitors targeting JAK/STAT signaling to effectively eliminate gastrointestinal CSC populations thought to be related to tumor metastasis, relapse, and therapeutic resistance.